Pregled bibliografske jedinice broj: 1254939
Selective laser trabeculoplasty as an add-on treatment in patients suffering from different types of glaucoma and not controlled on medical therapy
Selective laser trabeculoplasty as an add-on treatment in patients suffering from different types of glaucoma and not controlled on medical therapy // Book of abstracts of the 11th International Congress on Glaucoma Surgery
Ženeva, Švicarska, 2022. str. 7-7 (poster, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 1254939 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Selective laser trabeculoplasty as an add-on
treatment in patients suffering from different
types of glaucoma and not controlled on medical
therapy
Autori
Jandroković, Sonja ; Tomić, Martina ; Vidas Pauk, Sania ; Škegro, Ivan, Lešin Gaćina, Dina
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Book of abstracts of the 11th International Congress on Glaucoma Surgery
/ - , 2022, 7-7
Skup
11th International Congress on Glaucoma Surgery
Mjesto i datum
Ženeva, Švicarska, 21.04.2022. - 23.04.2022
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
selective laser trabeculoplasty ; add-on treatment ; glaucoma
Sažetak
Purpose: To evaluate the role of selective laser trabeculoplasty (SLT) as an add-on treatment for the primary open- angle glaucoma (POAG) and secondary pseudoexfoliative (PXFG) and pigmentary glaucoma (PG) in patients who were not controlled on maximum medical therapy Methods: A retrospective review of 39 glaucoma patients treated by SLT for insufficient intraocular pressure (IOP) control. Patients received SLT in a standard protocol. Data were recorded on the 0th day, the 1st day, and the 1st month after SLT. Success was defined as an IOP reduction of ≥ 20% at 1st month without the need for further medication, laser, or surgery. Results were were analyzed using Statistica software version 14.0. Results: Before SLT, the mean of IOP in was 23.54 ± 4.83 mmHg, and the median of glaucoma medications was 4 (2- 4). 1st month after SLT, a mean IOP significantly decreased to 19.64 ± 5.02 mmHg (p < 0.001). Out of 39 eyes, at 1st-month post-SLT, 19 (48.7%) eyes had at least a 20% reduction in IOP. The median and percentage of IOP reduction in all treated eyes were 3.5 (0-12) mmHg and 17.2 (0-40) %. The best IOP reduction effect was found in eyes with POAG (5 mmHg, 21.9%), and the slightest in PXFG (3 mmHg, 11.3%). Conclusion: SLT as an add-on treatment significantly reduces IOP and the number of local medications in different types of glaucoma. IOP reduction by SLT is the biggest in patients with POAG and the lowest in PXFG, although they have the greatest reduction in pressure immediately after the intervention.
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb